Amarantus Bioscience Holdings, Inc. Marching Towards a Revolutionary Therapy for Blindness and Diabetes in Wolfram Syndrome - KTEN.com - No One Gets You Closer

Amarantus Bioscience Holdings, Inc. Marching Towards a Revolutionary Therapy for Blindness and Diabetes in Wolfram Syndrome

Posted: Updated:
  • Texoma HeadlinesMore>>

  • Wild Horse & Burro Adoption Heading to Sulphur Springs, TX, August 1-2

    Wild Horse & Burro Adoption Heading to Sulphur Springs, TX, August 1-2

    The U.S. Bureau of Land Management (BLM) will hold a wild horse and burro adoption in Sulphur Springs, Texas, August 1-2, 2014. The two-day event at the Hopkins County Regional Civic Center will feature dozens of spectacular animals. These are adult and yearling horses and burros that once roamed free on public lands in the West. The BLM periodically removes excess animals from the range in order to maintain healthy herds and to protect other rangeland resources. The adoption program is essen...More >>
    The U.S. Bureau of Land Management (BLM) will hold a wild horse and burro adoption in Sulphur Springs, Texas, August 1-2, 2014. The two-day event at the Hopkins County Regional Civic Center will feature dozens of spectacular animals. These are adult and yearling horses and burros that once roamed free on public lands in the West. The BLM periodically removes excess animals from the range in order to maintain healthy herds and to protect other rangeland resources. The adoption program is essen...More >>
  • Marshall Co. Man Disappears After Night Of Drinking With Relatives

    Marshall Co. Man Disappears After Night Of Drinking With Relatives

    MARSHALL COUNTY, OK -- Deputies say it's been nearly 3 days since a man disappeared from a home near Madill after a night of drinking, and now they're hoping someone may have spotted him.More >>
    MARSHALL COUNTY, OK -- Deputies say it's been nearly 3 days since a man disappeared from a home near Madill after a night of drinking, and now they're hoping someone may have spotted him.More >>
  • Man Arrested in Connection to Bryan Co. Shooting

    Man Arrested in Connection to Bryan Co. Shooting

    BRYAN COUNTY, OK -- A man has been taken into custody in connection with a homicide investigation out of Bryan County. Officials say a man was found shot on Sunday night on the "Little Blue Bridge" in Blue, Oklahoma.More >>
    BRYAN COUNTY, OK -- A man has been taken into custody in connection with a homicide investigation out of Bryan County. Officials say a man was found shot on Sunday night on the "Little Blue Bridge" in Blue, Oklahoma.More >>

New York, NY / June 24, 2014 / Amarantus Bioscience Holdings, Inc. (OTCQB: AMBS) today published a guest blog post on The Chairman’s Blog, written by Dr. Fumihiko Urano, a researcher at the Washington University School of Medicine. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his guest blog post, Dr. Urano discusses the recently announced collaboration between the Washington University School of Medicine in St. Louis and Amarantus, in which his team will test the efficacy of MANF for the treatment of Wolfram’s syndrome and potentially, Type-1 diabetes. Commenting on the collaboration, Dr. Urano wrote, “Now that I have finally been able to forge a pact with Amarantus on an area where we share mutual interest…We are all hopeful that a breakthrough is on the horizon.” Read the full blog post from Dr. Fumihiko Urano on TheChairmansBlog.com (http://www.thechairmansblog.com/amarantus-bioscience/fumihiko-urano/marching-towards-revolutionary-therapy-blindness-diabetes-wolfram-syndrome/).

About Amarantus

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The Company has licensed Eltoprazine (“Eltoprazine”), a phase 2b ready indication for Parkinson’s Levodopa induced dyskinesia and Adult ADHD. The Company has an exclusive worldwide license to the Lymphocyte Proliferation test (“LymPro Test(R)”) for Alzheimer’s disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF”) and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property for the diagnosis of Parkinson’s disease (“NuroPro”) and the discovery of neurotrophic factors (“PhenoGuard”). For further information please visit www.Amarantus.com, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com 

SOURCE: The Chairmans Blog  

ReleaseID: 417188